To provide for the coordination of programs to prevent and treat obesity

HB 2912 would require health insurance plans in West Virginia to cover GLP-1 class medications (used to treat obesity and type 2 diabetes) when a patient has a valid prescription from a healthcare provider. This directly affects individuals with obesity or type 2 diabetes who are prescribed these medications, as well as insurance companies operating in the state. The bill amends state insurance law to mandate coverage for these specific medications without additional restrictions beyond a valid prescription. This change ensures patients can access these treatments without unexpected out-of-pocket costs due to insurance coverage gaps.